Can we preserve the benefits of probiotics while eliminating the problems associated with their use? The search for an answer to this question led to the development of a new field: postbiotics.
For decades, probiotics have been regarded as one of the main tools for supporting gut health. They have been used to restore microbial balance, improve digestion, and support the immune system.
And there were good reasons for this. Research has indeed confirmed the benefits of certain probiotic strains for some digestive disorders, including antibiotic-associated diarrhea and specific symptoms of irritable bowel syndrome.
Probiotics grew in popularity. Manufacturers offered more strains, increased the number of bacteria per serving, and developed new combinations.
However, it gradually became clear that increasing the number of bacteria did not always mean increasing the benefits.
The problem was not the idea of supporting the gut microbiota itself. The problem lay in the limitations of the traditional way of implementing it.
What is the main difference between postbiotics and probiotics?
Probiotics are a traditional approach to supporting the gut microbiome, whose effectiveness depends on specific strains, formulation, and individual characteristics. Postbiotics represent the next stage in the development of this approach: preserving the beneficial properties of microbial preparations while overcoming some of the limitations of probiotics—instability, difficulties with standardization, and tolerability issues. This is why NBHemp considers postbiotics a more promising technology for supporting gut health.
What Went Wrong with Probiotics?
Years of use and clinical research have revealed several significant problems.
1. Unpredictable Results
The same probiotic product may have a noticeable effect on one person and produce virtually no result in another.
The reason is that each person’s gut microbiota is unique. Microbial composition, diet, digestive health, and other factors can influence the body’s response.
Moreover, the beneficial properties of one bacterial strain cannot automatically be attributed to another.
Therefore, even a high-quality probiotic may not be suitable for a particular individual.
2. Bloating, Gas, and Discomfort
Paradoxically, products intended to improve digestion can themselves cause unpleasant sensations in some people.
Certain probiotics may cause gas, bloating, and temporary digestive discomfort.
This issue is particularly relevant for people with sensitive digestive systems, in whom even small changes in microbial activity may be accompanied by unpleasant symptoms.
As a result, an attempt to help the gut sometimes places an additional burden on the digestive system.
3. The Challenge of Maintaining Consistent Quality
Probiotics require microorganisms to remain viable throughout their stated shelf life.
Temperature, humidity, transportation, and storage conditions can affect the number of active bacteria.
Modern technologies successfully address many of these challenges, but monitoring viability remains an essential manufacturing requirement.
4. Billions of Bacteria Do Not Guarantee Results
The number of microorganisms in probiotics is usually expressed in CFU—colony-forming units.
Labels may list 10, 50, or even 100 billion CFU.
To consumers, this sounds convincing: the more bacteria, the better.
But scientific research shows that this is not a reliable way to choose a product.
Results depend primarily on the specific strain, its properties, dosage, and clinically demonstrated efficacy—not on the largest number printed on the package.
5. Limitations for Certain Groups of People
Most common probiotics are well tolerated by healthy individuals.
However, using live microorganisms requires additional caution in people with serious illnesses or severely weakened immune systems.
This is another factor limiting the universal applicability of the traditional approach.
The Central Question: How Can We Preserve the Benefits While Eliminating the Drawbacks?
All of these problems gradually led researchers to a fundamental question.
If the benefits of probiotics arise from their interactions with the gut, immune system, and microbiota, is it necessary to reproduce the traditional mechanism of administration?
Could we preserve the biologically beneficial properties of microorganisms while eliminating the technological and practical limitations associated with probiotics?
In other words, the goal was not to abandon the achievements of probiotic science.
Quite the opposite.
The goal was to apply the knowledge already gained to develop more stable, controllable, and convenient products.
One of the most promising answers to this question has been postbiotics.
Postbiotics: The Next Stage in Microbiome Technology
Postbiotics are based on the use of specially prepared microorganisms and their functional components.
During manufacturing, specific microbial strains are selected and grown under controlled conditions, then processed in a way that preserves the preparation’s necessary biological properties.
This makes it possible to use microbial material without requiring the bacteria to remain viable.
That fundamentally changes the technology.
Instead of having to maintain a specified number of live microorganisms, manufacturers can focus on standardizing composition, controlling functional components, and ensuring the reproducibility of the finished product’s properties.
In 2021, the international scientific association ISAPP established a definition of postbiotics as preparations of inactivated microorganisms and/or their components that provide a demonstrated health benefit.
Postbiotics have therefore become an independent scientific and technological field rather than simply another type of conventional probiotic.
Which Problems Associated with Probiotics Can Postbiotics Address?
Greater Technological Stability
Postbiotic preparations do not require bacteria to remain viable.
This can simplify storage and transportation, reduce the dependence of product quality on maintaining microbial viability, and expand the possibilities for creating convenient pharmaceutical and dietary supplement formats.
More Precise Control of Composition
Standardized manufacturing allows producers to control the amount of microbial material and the characteristics of its components.
This makes it possible to create preparations with reproducible specifications from batch to batch.
For consumers, this means clearer product characteristics; for manufacturers, additional opportunities for quality control.
A New Approach to Tolerability
With postbiotics, there is no need to introduce additional viable microorganisms into the digestive system.
This makes the postbiotic approach particularly interesting for people who experience discomfort when taking certain probiotics.
However, tolerability depends on the particular formulation: the absence of viable bacteria does not, by itself, guarantee the absence of adverse reactions.
The Ability to Preserve Beneficial Biological Activity
This is the point of greatest scientific interest.
It turns out that certain beneficial properties of microbial preparations can remain after the microorganisms have been processed.
Consequently, some of the benefits of the traditional approach may potentially be reproduced in a more technologically stable form.
But has this been demonstrated clinically?
Yes. And some results deserve particular attention.
Clinical Evidence: 200 Participants, 84 Days, and Nearly Identical Results
In 2024, the journal Gut Microbes published the results of a randomized, double-blind, placebo-controlled trial.
It involved 200 people with irritable bowel syndrome, predominantly characterized by diarrhea.
Researchers compared:
- A conventional probiotic based on Bifidobacterium longum CECT 7347 (ES1).
- A postbiotic preparation of the same strain—HT-ES1.
- Placebo.
The study lasted 84 days.
The results were particularly revealing.
Reduction in the severity of irritable bowel syndrome symptoms:
| Group | Change over 84 days |
|---|---|
| Probiotic ES1 | −59.6% |
| Postbiotic HT-ES1 | −60.8% |
| Placebo | −21.2% |
Both active groups demonstrated statistically significant improvements compared with placebo.
And here is what matters most.
The postbiotic preparation produced almost the same result as the conventional probiotic form of the same strain.
The difference between them was not established as clinical superiority of either form. But this is a fundamental finding for the development of postbiotic technologies.
It shows that, in certain cases, clinically meaningful effectiveness of a microbial preparation can be preserved while using a more controlled technological approach.
Moreover, by the end of the study, a reduction in abdominal pain of at least 30% was recorded in 88.06% of participants in the postbiotic group versus 28.79% in the placebo group.
These are not merely theoretical arguments; they are measurable results from a clinical study.
A Second Study: Postbiotics and Everyday Digestive Discomfort
Another study examined the postbiotic beLP1, based on Lactiplantibacillus plantarum.
The study enrolled 140 adults experiencing moderate digestive discomfort.
Participants received either the postbiotic or placebo for 84 days.
The main results showed a statistically significant improvement in the overall gastrointestinal symptom score in the postbiotic group:
- On Day 42: p = 0.0215.
- On Day 84: p = 0.0394.
Improvements were also recorded in certain measures of abdominal pain, dyspepsia, and digestion-related quality of life.
The researchers additionally observed changes in gut microbiota composition, including an increase in the relative abundance of certain microorganisms associated with the production of short-chain fatty acids.
The final per-protocol analysis included 103 participants.
This study matters for another reason: it shows that the postbiotic approach is of interest not only as a comparison with probiotics but also as an independent approach to supporting digestive comfort.
What Has Changed in Our Understanding of Gut Health Support?
Until recently, consumers were often encouraged to judge a probiotic mainly by the billions of bacteria it contained and the number of different strains.
Today, it is becoming clear that these are far from the most informative criteria.
It is much more important to understand what a particular microbial preparation does, how stable its composition is, and whether research supports its benefits.
Postbiotics make it possible to shift the focus from the quantity of microorganisms to the functional properties and quality of the finished product.
We consider this shift one of the most significant changes in the development of microbiome technologies.
Probiotics opened up enormous possibilities for using beneficial microorganisms.
Postbiotics offer a way to build on those achievements while overcoming some of the technological and practical limitations of the earlier approach.
Why NBHemp Chose to Focus on Postbiotics
Nutraceutical Bio Hemp (NBHemp), which has operated since 2018, is developing its own line of products to support the health of the gut microbiome.
In choosing a technology, we started with a straightforward goal:
Preserve the benefits of microbiome support while reducing dependence on the factors that complicate the use of conventional probiotics.
Four characteristics are especially important to us:
- Stability of the finished product.
- Standardized, controlled composition.
- Convenience for regular use.
- Attention to tolerability, particularly for people with sensitive digestion.
These principles formed the foundation for the development of NBH Postbiotic Pro.
This product represents a new direction that we see as a practical application of the postbiotic approach.
At the same time, the results of studies involving other postbiotic formulations are not direct evidence of the effectiveness of Postbiotic Pro: the benefits of any specific product depend on its own composition and research findings.
Our Conclusion: Why We Consider Postbiotics the Next Generation
The history of probiotics is a story of an important scientific achievement.
They helped us understand how closely human health is linked to intestinal microorganisms and demonstrated that influencing the microbiota can provide real benefits.
But limitations also emerged: inconsistent results, individual tolerability issues, dependence on bacterial viability, and challenges with standardization.
The development of postbiotics offers a new path.
It makes it possible to use the functional properties of microbial preparations, create more stable products, and expand the possibilities for controlling their composition.
Clinical research already shows that, for certain postbiotic preparations, this approach can produce meaningful beneficial effects.
Our position is therefore clear: postbiotics are not merely an alternative to probiotics but the next stage in the development of technologies for supporting the gut microbiome.
Not a rejection of the achievements of the past, but their further development.
It is in this field that we see considerable potential for modern microbiome science.
Scientific References
1. Salminen S. et al. (2021). The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nature Reviews Gastroenterology & Hepatology.
https://doi.org/10.1038/s41575-021-00440-6
2. A randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of live Bifidobacterium longum CECT 7347 (ES1) and heat-treated Bifidobacterium longum CECT 7347 (HT-ES1) in participants with diarrhea-predominant irritable bowel syndrome. Gut Microbes, 2024.
https://pubmed.ncbi.nlm.nih.gov/38630015/
3. Gut health and microbiome modulation by the heat-killed postbiotic beLP1® in adults with excess weight: a randomized, placebo-controlled trial. 2026.
https://pubmed.ncbi.nlm.nih.gov/42824179/
4. NIH Office of Dietary Supplements. Probiotics — Fact Sheet for Health Professionals.
https://ods.od.nih.gov/factsheets/Probiotics-HealthProfessional/
5. National Center for Complementary and Integrative Health (NCCIH). Probiotics: Usefulness and Safety.
https://www.nccih.nih.gov/health/probiotics-usefulness-and-safety
Nbhemp Archive Materials
The article draws on NBHemp’s archive of publications from previous years:
- “Postbiotics: The Next Generation of Microbiome Support.”
- “NBHemp Sensitive Postbiotic: A New Generation of Microbiome Support Products.”
- Materials discussing the advantages of postbiotics in terms of stability, standardization, and tolerability.
- Discussions of postbiotics in the context of SIBO and sensitive digestion.
Related points have been combined and repetitions removed. Additional clinical data are cited from the original scientific publications.
Leave a Reply